Atlas Trials

Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Clinical trial NCT00274963 · COMPLETED

Trial details

NCT number
NCT00274963
Sponsor
German CLL Study Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia
Start date
2004-10-01
Primary completion
2007-11-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.